Nicotine Édulcoré À L'acésulfame Potassique Et Au Sucralose Perrigo France (Nicotine Resinate)

Nicotine Resinate is used as a nicotine replacement therapy to address nicotine dependence and assist patients who wish to quit tobacco use.

• Smoking cessation: helps reduce cravings and withdrawal symptoms during the quitting process.
• Nicotine dependence: provides a regulated nicotine dose to facilitate gradual reduction.
• Tobacco use disorder: supports adults aiming to stop regular tobacco consumption.

• Nicotine Resinate dissociates after oral administration, releasing nicotine which binds to neuronal nicotinic acetylcholine receptors (nAChRs). Activation of these receptors mimics the pharmacologic effects of inhaled nicotine, reducing withdrawal symptoms and cravings while allowing a controlled tapering of nicotine exposure.

Nicotine Resinate may cause a range of adverse reactions that vary in frequency and severity.

Common Side Effects

• Nausea: mild to moderate stomach upset.
• Headache: transient pain often related to nicotine levels.
• Dizziness: sensation of light‑headedness, especially after first doses.
• Insomnia: difficulty falling or staying asleep.
• Irritation of the mouth or throat: mild local discomfort.
• Increased salivation: excess saliva production.

Serious or Rare Side Effects

• Cardiovascular events: chest pain, palpitations, or hypertension.
• Severe allergic reaction: rash, itching, swelling, or anaphylaxis.
• Persistent vomiting: may lead to dehydration.
• Mood changes: anxiety, irritability, or depressive symptoms.
• Gastrointestinal ulceration: rare but reported with prolonged high‑dose use.

When considering Nicotine Resinate, several safety measures should be observed.

• Cardiovascular risk: avoid use in patients with recent myocardial infarction or uncontrolled hypertension.
• Pregnancy and lactation: not recommended; consult a healthcare professional before use.
• Psychiatric conditions: monitor patients with anxiety, depression, or a history of seizures.
• Concomitant nicotine products: do not combine with other nicotine‑containing therapies.
• Age restriction: intended for adult use only; not for individuals under 18 years.
• Store at ambient temperature: keep below 25 °C, in the original container, protected from moisture and direct sunlight.

Nicotine Resinate can interact with other medicines, influencing their effects or safety profile.

Major Interactions (Avoid)

• Monoamine oxidase inhibitors (MAOIs): may increase hypertensive response.
• Beta‑blockers: nicotine‑induced tachycardia may reduce therapeutic efficacy.
• Warfarin: nicotine can alter hepatic metabolism, affecting anticoagulation control.

Moderate Interactions (Monitor Closely)

• Antidepressants (SSRIs, SNRIs): monitor for increased anxiety or insomnia.
• Antihypertensives: observe blood pressure for possible elevation.
• Caffeine‑containing products: may exacerbate jitteriness or palpitations.